Dirk Schadendorf: h-index, Total Citations, and Citation Map
Dirk Schadendorf's h-index is 193 (1021 i10-index, 253,630+ total citations across 1,000+ publications) according to Google Scholar as of July 2026. Dirk Schadendorf is affiliated with Professor für Dermatologie, University Hospital Essen; University of Duisburg-Essen.
Dirk Schadendorf is a researcher affiliated with Professor für Dermatologie, University Hospital Essen; University of Duisburg-Essen, specializing in Cancer, melanoma, translational research. Their work has been cited 253,630 times. This profile visualizes their global influence, spanning a global audience.
Dirk Schadendorf's Citation Metrics
Bibliometric impact based on 1,000 indexed publications.
- H-Index
- 193
- i10-Index
- 1021
- Total Citations
- 253,630
- Citing Countries
- 0
As of July 2026.
Dirk Schadendorf has an h-index of 193 and 253,630 total citations across 1000 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Dirk Schadendorf's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 253,630 citations for Dirk Schadendorf
We've shown the most-cited 5,000. Unlock the full crawl (248,630 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Improved survival with ipilimumab in patients with metastatic melanoma
201019,273
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Dirk Schadendorf's research
Dirk Schadendorf is a researcher in Cancer, melanoma and translational research at Professor für Dermatologie, University Hospital Essen; University of Duisburg-Essen. Their work has been cited 253,630 times across 1,000 publications (h-index 193), according to Google Scholar.
Their most-cited work, “Improved survival with ipilimumab in patients with metastatic melanoma” (2010), has accumulated 19,273 citations. Other influential works include “Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma” (2015) with 10,371 citations and “Improved survival with vemurafenib in melanoma with BRAF V600E mutation” (2011) with 9,944 citations.











